No Data
Take Care Before Jumping Onto Mabpharm Limited (HKG:2181) Even Though It's 28% Cheaper
MABPHARM-B: 2024 Annual Report
Mabpharm Shrinks Loss by 39% in 2024
MABPHARM-B (02181) announced its performance for the fiscal year 2024, reporting a net loss of 0.128 billion yuan, a year-on-year narrowing of 38.9%.
MABPHARM-B (02181) published its 2024 annual performance, revenue of 0.258 billion yuan (RMB,...
Express News | Mabpharm FY Revenue RMB 258.2 Million
Express News | Mabpharm FY Gross Profit RMB 219.4 Million
Some Mabpharm Limited (HKG:2181) Shareholders Look For Exit As Shares Take 41% Pounding